Aaron Kesselheim (2009 Awardee) co-authors "Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers" in Health Affairs Vol. 36, No. 2, January 27, 2017, in "Pharma teams up with rare-disease advocacy groups on Capitol Hill" in Spectrum News, April 11, and in "Defiant, Generic Drug Maker Continues to Raise Prices" in The New York Times, April 14, 2017.
News Source:
Date:
Friday, April 14, 2017
Investigator: